Cited by 498Cystic Fibrosis Research AdvancesNursing care and researchChronic Obstructive Pulmonary Disease (COPD) Research

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

High treatment burden in adults with cystic fibrosis: Challenges to disease self-management

Open access

Sawicki, Gregory S., Sellers, Deborah E., Robinson, Walter M.·2009·Journal of Cystic Fibrosis

DOI 10.1016/j.jcf.2008.09.007PMC PMC2680350

Open this paper in CoChat — free account Open PDF

Abstract

Background More aggressive management of cystic fibrosis (CF), along with the use of new therapies, has led to increasing survival. Thus, the recommended daily treatment regimens for most CF adults are complex and time consuming. Methods In the Project on Adult Care in CF (PAC-CF), an ongoing longitudinal study of CF adults, we assessed self-reported daily treatment activities and perceived treatment burden as measured by the CF Questionnaire-Revised (CFQ-R), a disease-specific quality of life measure. Results Among the 204 respondents, the median number of daily therapies reported was 7 (IQR 5-9) and the mean reported time spent on treatment activities was 108 minutes per day (SD 58 minutes). Respondents reported a median of 3 inhaled and 3 oral therapies on the day prior to the survey. Only 49% reported performing airway clearance (ACT) on that day. There were no differences in the number of medications or the time to complete therapies based on gender, age or FEV1. The mean CFQ-R treatment burden domain score was 52.3 (SD 22.1), with no significant differences in the treatment burden based on age or FEV1. In a multivariable model controlling for age, gender, and FEV1, using 2 or more nebulized medications and performing ACT for ≥30 minutes were significantly associated with increased treatment burden. Conclusion The level of daily treatment activity is high for CF adults regardless of age or disease severity. Increasing number of nebulized therapies and increased ACT time, but not gender, age, or pulmonary function, is associated with higher perceived treatment burden. Efforts to assess the effects of high treatment burden on outcomes such as quality of life are warranted.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jcf.2008.09.007

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,671
Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions
Leventhal, H., Diefenbach, M., & Leventhal, E. A. (1992) · Cognitive Therapy and Research · doi:10.1007/bf01173486 · Cited by 1,573
Cystic Fibrosis Pulmonary Guidelines
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey‐Courand, D. B., Bujan, J., Finder, J. D., Lester, M., Quittell, L. M., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Mucus Clearance and Lung Function in Cystic Fibrosis with Hypertonic Saline
Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043891 · Cited by 689
Cystic Fibrosis Adult Care
Yankaskas, J. R., Marshall, B. C., Sufian, B. S., Simon, R. H., & Rodman, D. M. (2004) · CHEST Journal · doi:10.1378/chest.125.1_suppl.1s · Cited by 574
Development and Validation of the Cystic Fibrosis Questionnaire in the United States
Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M. L. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2347 · Cited by 525
Barriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?
Modi, A. C., & Quittner, A. L. (2006) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsj096 · Cited by 301
Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
Geller, D. E., Konstan, M. W., Smith, J. J., Noonberg, S. B., & Conrad, C. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20594 · Cited by 195
Determinants of adherence in adults with cystic fibrosis
Kettler, L. J. (2002) · Thorax · doi:10.1136/thorax.57.5.459 · Cited by 147

Flagged first, then by citations

Show all 15 references

Sorted by citations

Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M., Dunitz, J., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909825 · Cited by 803
Measuring the Transition Readiness of Youth with Special Healthcare Needs: Validation of the TRAQ—Transition Readiness Assessment Questionnaire
Sawicki, G. S., Lukens-Bull, K., Yin, X., Demars, N., Huang, I.-C., Livingood, W., Reiss, J., & Wood, D. (2011) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsp128 · Cited by 592
Self-citation
Cystic fibrosis
Ratjen, F. A., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 575
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety.
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., Marshall, B., Sabadosa, K. A., & Elborn, S. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207488 · Cited by 465
Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry
MacKenzie, T. A., Gifford, A. H., Sabadosa, K. A., Quinton, H. B., Knapp, E. A., Goss, C. H., & Marshall, B. C. (2014) · Annals of Internal Medicine · doi:10.7326/m13-0636 · Cited by 352
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
Konstan, M. W., Flume, P. A., Kappler, M., Chiron, R., Higgins, M., Brockhaus, F., Zhang, J., Angyalosi, G., He, E., & Geller, D. E. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2010.10.003 · Cited by 313
Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
Geller, D. E., Weers, J. G., & Heuerding, S. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0855 · Cited by 306
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Sermet‐Gaudelus, I., Boeck, K. D., Casimir, G. J., Vermeulen, F. L., Leal, T., Mogenet, A., Roussel, D., Fritsch, J., Hanssens, L. S., Hirawat, S., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0137oc · Cited by 248
The relative frequency of CFTR mutation classes in European patients with cystic fibrosis
Boeck, K. D., Zolin, A., Cuppens, H., Olesen, H. V., & Viviani, L. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.12.003 · Cited by 229
Cystic Fibrosis and Transition to Adult Medical Care
Tuchman, L. K., Schwartz, L. A., Sawicki, G. S., & Britto, M. T. (2010) · PEDIATRICS · doi:10.1542/peds.2009-2791 · Cited by 213
Self-citation
Accurate Assessment of Adherence
Daniels, T., Goodacre, L., Sutton, C., Pollard, K., Conway, S., & Peckham, D. (2011) · Chest · doi:10.1378/chest.09-3074 · Cited by 210
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
Schuster, A., Haliburn, C., Döring, G., Goldman, M. H., & for the Freedom Study Group (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202059 · Cited by 206
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
Bell, S. C., Boeck, K. D., & Amaral, M. D. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.005 · Cited by 182
Dornase alfa for cystic fibrosis
Yang, C. L., Chilvers, M. A., Montgomery, M. D., & Nevitt, S. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001127.pub3 · Cited by 159
Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions
Eton, D. T., Ridgeway, J. L., Egginton, J. S., Tiedje, K., Linzer, M., Boehm, D. H., Poplau, S., de Oliveira, D. R., Odell, L., Montori, V. M., et al. (2015) · Patient Related Outcome Measures · doi:10.2147/prom.s78955 · Cited by 152
Treatment complexity in cystic fibrosis: Trends over time and associations with site-specific outcomes
Sawicki, G. S., Ren, C. L., Konstan, M. W., Millar, S. J., Pasta, D. J., & Quittner, A. L. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.12.009 · Cited by 154
Self-citation
Brazilian guidelines for the diagnosis and treatment of cystic fibrosis
Athanazio, R. A., Filho, L. V. R. F. D. S., Vergara, A. A., Ribeiro, A. F., Riedi, C. A., Procianoy, E. D. F. A., Adde, F. V., Reis, F. J. C., Ribeiro, J. D., Torres, L. A. G. M. M., et al. (2017) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000065 · Cited by 180
Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study
Bilton, D., Robinson, P. J., Cooper, P., Gallagher, C. G., Kolbe, J., Fox, H., Jaques, A., & Charlton, B. (2011) · European Respiratory Journal · doi:10.1183/09031936.00187510 · Cited by 150
Inhaled Medicines: Past, Present, and Future
Anderson, S. D., Atkins, P. J., Bäckman, P., Cipolla, D. C., Clark, A., Daviskas, E., Disse, B. G., Entcheva‐Dimitrov, P., Fuller, R. W., Gonda, I., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000108 · Cited by 157
User Preferences and Design Recommendations for an mHealth App to Promote Cystic Fibrosis Self-Management
Hilliard, M. E., Hahn, A. L., Ridge, A. K., Eakin, M. N., & Riekert, K. A. (2014) · JMIR mhealth and uhealth · doi:10.2196/mhealth.3599 · Cited by 140
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
Mayer-Hamblett, N., Ratjen, F. A., Russell, R., Donaldson, S. H., Riekert, K. A., Sawicki, G. S., Odem‐Davis, K., Young, J., Rosenbluth, D., Taylor‐Cousar, J. L., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00434-9 · Cited by 140
Self-citation
Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample
Quittner, A. L., Sawicki, G. S., McMullen, A. H., Rasouliyan, L., Pasta, D. J., Yegin, A., & Konstan, M. W. (2011) · Quality of Life Research · doi:10.1007/s11136-011-0036-z · Cited by 139
Self-citation
A Systematic Review of Factors Associated with Health-Related Quality of Life in Adolescents and Adults with Cystic Fibrosis
Habib, A.-R. R., Manji, J., Wilcox, P., Javer, A. R., Buxton, J. A., & Quon, B. S. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201408-393oc · Cited by 134
Inhaled antimicrobial therapy – Barriers to effective treatment
Weers, J. G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.013 · Cited by 129
Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
Dagenais, R., Su, V., & Quon, B. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010023 · Cited by 136
Measuring and improving respiratory outcomes in cystic fibrosis lung disease: Opportunities and challenges to therapy
Zemanick, E. T., Harris, J. K., Conway, S., Konstan, M. W., Marshall, B. C., Quittner, A. L., Retsch‐Bogart, G. Z., Saiman, L. M., & Accurso, F. J. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.09.003 · Cited by 113
Motivating adherence among adolescents with cystic fibrosis: Youth and parent perspectives
Sawicki, G. S., Heller, K. S., Demars, N., & Robinson, W. M. (2014) · Pediatric Pulmonology · doi:10.1002/ppul.23017 · Cited by 108
Self-citation
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis
Sawicki, G. S., Rasouliyan, L., McMullen, A. H., Wagener, J. S., McColley, S. A., Pasta, D. J., & Quittner, A. L. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21325 · Cited by 106
Self-citation
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials
Davies, G., Rowbotham, N. J., Smith, S., Elliot, Z. C., Gathercole, K., Rayner, O., Leighton, P. A., Herbert, S., Duff, A. J., Chandran, S., et al. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.10.025 · Cited by 99
Managing treatment complexity in cystic fibrosis: Challenges and Opportunities
Sawicki, G. S., & Tiddens, H. A. W. M. (2012) · Pediatric Pulmonology · doi:10.1002/ppul.22546 · Cited by 104
Self-citation
Dornase alfa for cystic fibrosis
Yang, C., & Montgomery, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001127.pub4 · Cited by 101
Adherence to therapies in cystic fibrosis: a targeted literature review
Narayanan, S., Mainz, J. G., Gala, S., Tabori, H., & Grossoehme, D. H. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1280399 · Cited by 97
Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data
Frost, F. J., Nazareth, D. S., Charman, S. C., Winstanley, C., & Walshaw, M. J. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201902-122oc · Cited by 97
Lifestyle interventions to reduce sedentary behaviour in clinical populations: A systematic review and meta-analysis of different strategies and effects on cardiometabolic health
Nieste, I., Franssen, W. M. A., Spaas, J., Bruckers, L. M., Savelberg, H. H. C. M., & Eijnde, B. O. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106593 · Cited by 100
Regimen Complexity and Prescription Adherence in Dialysis Patients
Neri, L., Martini, A., Andreucci, V. E., Gallieni, M. A., Rey, L. A. R., Brancaccio, D., & and the MigliorDialisi Study Group (2011) · American Journal of Nephrology · doi:10.1159/000328391 · Cited by 95
Caregiver burden of parents of young children with cystic fibrosis.
Fitzgerald, C., George, S., Somerville, R., Linnane, B., & Fitzpatrick, P. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.08.016 · Cited by 86
Fibrous dysplasia and cemento-ossifying fibroma. A histologic spectrum.
Voytek, T. M., Ro, J. Y., Edeiken, J., & Ayala, A. G. (1995) · PubMed · Cited by 91
Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
Burgel, P., Southern, K. W., Addy, C., Battezzati, A., Berry, C. A., Bouchara, J., Brokaar, E. J., Brown, A. W., Azevedo, P., Durieu, I., et al. (2024) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2024.01.005 · Cited by 101
Treatment adherence and health outcomes in patients with bronchiectasis
McCullough, A. R., Tunney, M. M., Quittner, A. L., Elborn, J. S., Bradley, J. M., & Hughes, C. M. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-107 · Cited by 87
Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample
Quittner, A. L., Sawicki, G. S., McMullen, A. H., Rasouliyan, L., Pasta, D. J., Yegin, A., & Konstan, M. W. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0091-5 · Cited by 85
Self-citation
Dornase alfa for cystic fibrosis
Yang, C. L., & Montgomery, M. D. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001127.pub5 · Cited by 82
Fatigue in Chronic Respiratory Diseases: Theoretical Framework and Implications For Real-Life Performance and Rehabilitation
Gruet, M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01285 · Cited by 82
Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report
Henkle, E. M., Aksamit, T. R., BARKER, A. R., Daley, C. L., Griffith, D. E., Leitman, P., Leitman, A., Malanga, E., Marras, T. K., Olivier, K. N., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-387ws · Cited by 77
Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis.
Hilliard, M. E., Eakin, M. N., Borrelli, B., Green, A., & Riekert, K. A. (2014) · Health Psychology · doi:10.1037/hea0000136 · Cited by 77
Exercise as part of a cystic fibrosis therapeutic routine
Rand, S., & Prasad, S. A. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.19 · Cited by 75
Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
Whelan, F., Heirali, A., Rossi, L., Rabin, H. R., Parkins, M. D., & Surette, M. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172811 · Cited by 71
A systematic literature review of the assessment of treatment burden experienced by patients and their caregivers
Sheehan, O. C., Leff, B. A., Ritchie, C. S., Garrigues, S. K., Li, L., Saliba, D., Fathi, R., & Boyd, C. M. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1222-z · Cited by 72
The impact of medication adherence on lung health outcomes in cystic fibrosis
Eakin, M. N., & Riekert, K. A. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283659f45 · Cited by 71
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: A multicentre, open-label, randomised trial
Ballmann, M., Hubert, D., Assael, B. M., Staab, D., Hebestreit, A., Naehrlich, L., Nickolay, T., Prinz, N., Holl, R. W., Staden, U., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30400-x · Cited by 71
Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment
Filho, L. V. R. F. D. S., Ferreira, F. D. A., Reis, F. J. C., de Britto, M. C. A., Levy, C. E., Clark, O. A. C., & Ribeiro, J. D. (2013) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132013000400015 · Cited by 70
Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
Parkins, M. D., Parkins, V. M., Rendall, J. C., & Elborn, J. S. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810386051 · Cited by 69
Associations between illness perceptions and health-related quality of life in adults with cystic fibrosis
Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.06.005 · Cited by 68
Self-citation
Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis
Bishay, L. C., & Sawicki, G. S. (2016) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s95637 · Cited by 74
Self-citation
Therapeutic challenges posed by critical drug–drug interactions in cystic fibrosis
Jordan, C. L., Noah, T. L., & Henry, M. M. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23505 · Cited by 65
Rehabilitation in Patients with Chronic Respiratory Disease Other than Chronic Obstructive Pulmonary Disease: Exercise and Physical Activity Interventions in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
Burtin, C., & Hebestreit, H. U. (2015) · Respiration · doi:10.1159/000375170 · Cited by 70
Screening for cystic fibrosis-related diabetes: a systematic review.
Waugh, N. R., Royle, P., Craigie, I., Ho, V. K. Y., Pandit, L., Ewings, P., Adler, A., Helms, P. J. B., & Sheldon, C. D. (2012) · Health Technology Assessment · doi:10.3310/hta16240 · Cited by 64
Effectiveness of a Home-Based Active Video Game Programme in Young Cystic Fibrosis Patients
del Corral, T., Iranzo, M. À. C. I., López‐de‐Uralde‐Villanueva, I., Martínez-Alejos, R., Blanco, I., & Vilaró, J. (2017) · Respiration · doi:10.1159/000481264 · Cited by 64
The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
Heirali, A., Workentine, M. L., Acosta, N., Poonja, A., Storey, D. G., Somayaji, R., Rabin, H. R., Whelan, F., Surette, M. G., & Parkins, M. D. (2017) · Microbiome · doi:10.1186/s40168-017-0265-7 · Cited by 60
Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)
Harrison, M. J., McCarthy, M. M., Fleming, C., Hickey, C., Shortt, C., Eustace, J., Murphy, D. M., & Plant, B. J. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.04.004 · Cited by 59
Young Adult Palliative Care
Clark, J. K., & Fasciano, K. M. (2013) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909113510394 · Cited by 59
Longitudinal Trends in Health-Related Quality of Life in Adults With Cystic Fibrosis
Dill, E. J., Dawson, R., Sellers, D. E., Robinson, W. M., & Sawicki, G. S. (2013) · CHEST Journal · doi:10.1378/chest.12-1404 · Cited by 60
Self-citation
Self-management for bronchiectasis
Kelly, C. A., Grundy, S., Lynes, D., Evans, D. J., Gudur, S., Milan, S. J., & Spencer, S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012528.pub2 · Cited by 62
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design
Mayer-Hamblett, N., Nichols, D. P., Odem‐Davis, K., Riekert, K. A., Sawicki, G. S., Donaldson, S. H., Ratjen, F. A., Konstan, M. W., Simon, N., Rosenbluth, D., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202010-1336sd · Cited by 59
Self-citation
Adherence of Subjects With Cystic Fibrosis to Their Home Program: A Systematic Review
O'Donohoe, R., & Fullen, B. M. (2014) · Respiratory Care · doi:10.4187/respcare.02990 · Cited by 54
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
Willsie, S. K. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00228-8 · Cited by 55
Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial
Wildman, M. J., O’Cathain, A., Maguire, C., Arden, M. A., Hutchings, M., Bradley, J., Walters, S. J., Whelan, P., Ainsworth, J., Buchan, I., et al. (2022) · Thorax · doi:10.1136/thoraxjnl-2021-217594 · Cited by 54
Validation of the Treatment Satisfaction Questionnaire for Medication in patients with cystic fibrosis
Regnault, A., Balp, M., Kulich, K. R., & Viala-Danten, M. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.04.007 · Cited by 54
Physical activity participation by adults with cystic fibrosis: An observational study
Cox, N. S., Alison, J. A., Button, B., Wilson, J. W., Morton, J. M., & Holland, A. E. (2015) · Respirology · doi:10.1111/resp.12719 · Cited by 56
Effects of exercise and airway clearance (positive expiratory pressure) on mucus clearance in cystic fibrosis: a randomised crossover trial
Dwyer, T., Daviskas, E., Zainuldin, R., Verschuer, J., Eberl, S., Bye, P. T. P., & Alison, J. A. (2019) · European Respiratory Journal · doi:10.1183/13993003.01793-2018 · Cited by 54
Colistimethate Sodium Dry Powder for Inhalation: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
Conole, D., & Keating, G. M. (2014) · Drugs · doi:10.1007/s40265-014-0181-0 · Cited by 53
Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001–2007
Briesacher, B. A., Quittner, A. L., Fouayzi, H., Zhang, J., & Swensen, A. R. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21441 · Cited by 52
Cystic Fibrosis: What to Expect now in the Early Adult Years
Quon, B. S., & Aitken, M. L. (2012) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2012.03.005 · Cited by 54
Inhaled mannitol for cystic fibrosis
Nevitt, S. J., Thornton, J., Murray, C. S., & Dwyer, T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008649.pub2 · Cited by 51
Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross-sectional study
Duff, A. J. A., Abbott, J., Cowperthwaite, C., Sumner, C., Hurley, M. A., & Quittner, A. L. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.02.010 · Cited by 51
Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy
Gifford, A. H., Mayer-Hamblett, N., Pearson, K., & Nichols, D. P. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.11.007 · Cited by 54
Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes
Oates, G. R., Štěpáníková, I., Gamble, S., Gutierrez, H. H., & Harris, W. T. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23317 · Cited by 50
P seudomonas aeruginosa antibiotic resistance in A ustralian cystic fibrosis centres
Smith, D. B., Ramsay, K. A., Yerkovich, S. T., Reid, D. W., Wainwright, C. E., Grimwood, K., Bell, S. C., & Kidd, T. J. (2015) · Respirology · doi:10.1111/resp.12714 · Cited by 50
Effects of treadmill exercise versus Flutter® on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial
Dwyer, T., Zainuldin, R., Daviskas, E., Bye, P. T. P., & Alison, J. A. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0360-8 · Cited by 50
The I-neb Adaptive Aerosol Delivery System Enhances Delivery of α1-Antitrypsin with Controlled Inhalation
Geller, D. E., & Kesser, K. C. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0793 · Cited by 49
Patient experience after kidney transplant: a conceptual framework of treatment burden
Lorenz, E. C., Egginton, J. S., Stegall, M. D., Cheville, A. L., Heilman, R. L., Nair, S. S., Mai, M. L., & Eton, D. T. (2019) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-019-0095-4 · Cited by 47
An exploratory study investigating factors associated with adherence to chest physiotherapy and exercise in adults with cystic fibrosis
Myers, L. B. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.08.005 · Cited by 47
Cystic Fibrosis and Its Management Through Established and Emerging Therapies
Spielberg, D. R., & Clancy, J. P. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-050024 · Cited by 48
An Update on CFTR Modulators as New Therapies for Cystic Fibrosis
King, J. A., Nichols, A.-L., Bentley, S., Carr, S. B., & Davies, J. C. (2022) · Pediatric Drugs · doi:10.1007/s40272-022-00509-y · Cited by 47
Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub
Arden, M. A., Hutchings, M., Whelan, P., Drabble, S. J., Beever, D., Bradley, J. M., Hind, D., Ainsworth, J., Maguire, C., Cantrill, H., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00739-2 · Cited by 44
Translating rare-disease therapies into improved care for patients and families: what are the right outcomes, designs, and engagement approaches in health-systems research?
Potter, B. K., Khangura, S. D., Tingley, K., Chakraborty, P. K., & Little, J. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.42 · Cited by 46
Nebuliser systems for drug delivery in cystic fibrosis
Daniels, T. E., Mills, N., & Whitaker, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007639.pub2 · Cited by 46
Opportunities for cystic fibrosis care teams to support treatment adherence
Riekert, K. A., Eakin, M. N., Bilderback, A. L., Ridge, A. K., & Marshall, B. C. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.10.003 · Cited by 47
Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence
Hamed, K. A., & DeBonnett, L. (2017) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465817691239 · Cited by 45
Patient-perceived treatment burden of chronic obstructive pulmonary disease
Harb, N., Foster, J., & Dobler, C. C. (2017) · International Journal of COPD · doi:10.2147/copd.s130353 · Cited by 46
Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?
Schneider‐Futschik, E. K., Reyes‐Ortega, F., Li, J., & Velkov, T. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.548 · Cited by 45
Rethinking physical exercise training in the modern era of cystic fibrosis: A step towards optimising short-term efficacy and long-term engagement
Gruet, M., SAYNOR, Z. L., Urquhart, D. S., & Radtke, T. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.08.004 · Cited by 53
Treatment Preference Among People With Cystic Fibrosis
Cameron, R. A., Daniel Office, Matthews, J., Rowley, M., Abbott, J., Simmonds, N. J., Whitty, J. A., & Carr, S. B. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.07.008 · Cited by 47
Predictors of adherence to treatment in bronchiectasis
McCullough, A. R., Tunney, M. M., Elborn, J. S., Bradley, J. M., & Hughes, C. M. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.04.011 · Cited by 42
Adherence to medication in adults with Cystic Fibrosis: An investigation using objective adherence data and the Theoretical Domains Framework
Arden, M. A., Drabble, S. J., O’Cathain, A., Hutchings, M., & Wildman, M. J. (2019) · British Journal of Health Psychology · doi:10.1111/bjhp.12357 · Cited by 45
A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: Results of a randomised controlled trial
Wood, J., JENKINS, S. C., Putrino, D. F., Mulrennan, S. A., Morey, S., Cecins, N. M., Bear, N., & Hill, K. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.09.002 · Cited by 41
Multi-modality monitoring of cystic fibrosis lung disease: The role of chest computed tomography
Tiddens, H. A. W. M., Stick, S. M., & Davis, S. D. (2013) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2013.05.003 · Cited by 41
Tackling the increasing complexity of CF care
Sawicki, G. S., & Goss, C. H. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23244 · Cited by 41
Self-citation
Longitudinal association between lung function and health-related quality of life in cystic fibrosis
Abbott, J., Hurley, M. A., Morton, A. M., & Conway, S. P. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202552 · Cited by 40
Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group
Geller, D. E., Nasr, S. Z., Piggott, S., He, E., Angyalosi, G., & Higgins, M. (2013) · Respiratory Care · doi:10.4187/respcare.02264 · Cited by 40

Authors: Sawicki, G. S., Sellers, D. E., & Robinson, W. M.
Affiliations: Boston Children's Hospital (US)
Education Development Center (US)
Corresponding author: Sawicki, Gregory S.
ORCID: Sawicki, Gregory S.
Sellers, Deborah E.
Venue: Journal of Cystic Fibrosis
Publisher: Elsevier BV
Published: 2009-03
Volume: 8
Issue: 2
Pages: 91-96
ISSN: 1569-1993 (ISSN-L)
DOI: 10.1016/j.jcf.2008.09.007
PMC: PMC2680350
OpenAlex: W1976264709
Semantic Scholar: 6f4fe4eb5aa680de9ed1e2a38ba023699f8c2d53
Cited by: 498
References: 15
Citations by year: 2026: 15 · 2025: 25 · 2024: 29 · 2023: 41 · 2022: 46 · 2021: 32 · 2020: 35 · 2019: 35 · 2018: 30 · 2017: 39 · 2016: 25 · 2015: 37 · 2014: 29 · 2013: 23 · 2012: 15
FWCI: 12.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1598 d)
Locations: Journal of Cystic Fibrosis (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01 HL72938, R01HL072938)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Health Sciences › Nursing › Research and Theory › Nursing care and research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords: treatment burden, disease self-management, adults with cystic fibrosis, airway clearance, quality of life, lung function
MeSH terms: Adult, Age Factors, Cystic Fibrosis, Female, Humans, Longitudinal Studies, Male, Quality of Life, Surveys and Questionnaires, Respiratory Therapy, Self Care, Severity of Illness Index, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High treatment burden in adults with cystic fibrosis: Challenges to disease self-management

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks